
Medicare recipients get access to cheap GLP-1 drugs starting July 1
CMS pilot opens subsidized access to obesity drugs for Medicare Part D enrollees through 2027, but long-term coverage questions remain
News & Analysis on Food & Beverage Development & Technology

CMS pilot opens subsidized access to obesity drugs for Medicare Part D enrollees through 2027, but long-term coverage questions remain

From WPC80 to lactoferrin, dairy companies globally are investing in premium protein capacity to capture growth in the high-end sports nutrition and functional food space

The Ingredion-Tate & Lyle deal signals a shift in the ingredients industry, where technical expertise is becoming as valuable as the ingredients themselves